Annovis Bio Inc (ANVS)

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc ... - Business Wire

Business Wire

Annovis Bio Inc put volume heavy and directionally bearish - TipRanks.com - TipRanks

TipRanks

The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors - Business Wire

Business Wire

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks Investment Research

HC Wainwright Analysts Raise Earnings Estimates for Annovis Bio, Inc. (NYSE:ANVS) - Defense World

Defense World

HC Wainwright Analysts Raise Earnings Estimates for Annovis Bio, Inc. (NYSE:ANVS) - Defense World

Defense World

Behind the Scenes of Annovis Bio's Latest Options Trends - Annovis Bio (NYSE:ANVS) - Benzinga

Benzinga

HC Wainwright Analysts Boost Earnings Estimates for Annovis Bio, Inc. (NYSE:ANVS) - MarketBeat

MarketBeat

Annovis Bio reports Q1 EPS (72c), consensus (80c) - TipRanks.com - TipRanks

TipRanks

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Zacks Investment Research

Annovis Bio (NYSE:ANVS) Price Target Cut to $23.00 by Analysts at HC Wainwright - MarketBeat

MarketBeat

Largest borrow rate increases among liquid names - TipRanks.com - TipRanks

TipRanks

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results - GlobeNewswire

GlobeNewswire

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results - Yahoo Finance

Yahoo Finance

Annovis Bio Inc put volume heavy and directionally bearish - TipRanks.com - TipRanks

TipRanks

Is Annovis Bio (ANVS) Stock Outpacing Its Medical Peers This Year? - Yahoo Movies Canada

Yahoo Movies Canada

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Zacks Investment Research

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Zacks Investment Research

Annovis Bio stock gains on plans for Parkinson's readout - Seeking Alpha

Seeking Alpha

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Zacks Investment Research

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's Disease - Yahoo Finance

Yahoo Finance

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Zacks Investment Research

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Zacks Investment Research

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Zacks Investment Research

Wall Street Analysts See a 213.78% Upside in Annovis Bio, Inc. (ANVS): Can the Stock Really Move This High? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Zacks Investment Research

Annovis (ANVS) Gains on FDA Authorization for AD Study - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Annovis Bio, Inc. (ANVS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Annovis Bio Issues Key Update on Corporate Progress - TipRanks.com - TipRanks

TipRanks

Annovis Bio refines Alzheimer's trial approach after Phase II/III data - Investing.com Nigeria

Investing.com Nigeria

Annovis Bio refines Alzheimer's trial approach after Phase II/III data - Investing.com

Investing.com

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

GlobeNewswire Inc.

Annovis Bio Issues Key Update on Corporate Progress - TipRanks.com - TipRanks

TipRanks

Annovis Bio (NYSE:ANVS) Stock Rating Reaffirmed by HC Wainwright - Defense World

Defense World

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zacks Investment Research

Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market (NYSE:ANVS) - Seeking Alpha

Seeking Alpha

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research

Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects (NYSE:ANVS) - Seeking Alpha

Seeking Alpha

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

Zacks Investment Research

Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market (NYSE:ANVS) - Seeking Alpha

Seeking Alpha

Annovis: Alzheimer's Phase 2/3 Topline Readout Puts Buntanetap Future Into Question (ANVS) - Seeking Alpha

Seeking Alpha

Annovis battles stock slide, heads for a phase III in Alzheimer's - BioWorld Online

BioWorld Online

Annovis Bio Target of Unusually Large Options Trading (NYSE:ANVS) - MarketBeat

MarketBeat

Annovis Bio reports cognitive gains in Alzheimer's study - Investing.com

Investing.com

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

GlobeNewswire Inc.

Annovis Bio plunges on mid-stage data from Alzheimer's treatment - XM

XM

Wall Street Breakfast: The Week Ahead

Seeking Alpha

FOMC Meeting, Jobs Report, And Apple Earnings Headline Big Week

Seeking Alpha

Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade

Zacks Investment Research

Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade - Yahoo Finance

Yahoo Finance